DermAbiotech develops innovative targeted therapies for acute T cell-mediated inflammatory diseases.
-
Swiss Biotech AssociationNot a member
- Claim / update listing
DermAbiotech develops innovative targeted therapies for acute T cell-mediated inflammatory diseases.
Route de Florissant 53, 1206 Genève, Switzerland